(ACRI-B) Acrinova Series - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015660030
ACRI-B EPS (Earnings per Share)
ACRI-B Revenue
ACRI-B: Residential, Commercial, Industrial, Hospitality
Acrinova AB (publ) is a Swedish real estate company that specializes in owning, developing, and managing a diverse portfolio of properties, including residential units, retail spaces, commercial premises, offices, warehouses, and industrial facilities. With its headquarters in Malmö, Sweden, the company was established in 2014 and has since grown to become a significant player in the Swedish property market. For more information, visit their official website at https://www.acrinova.se.
As a Real Estate Operating Company, Acrinova ABs stock (ACRI-B) is listed on the Swedish stock exchange. The companys business model involves generating revenue through rental income from its property portfolio, which is diversified across various sectors, reducing dependence on any single market segment. This diversification can potentially provide a stable source of income and mitigate risks associated with market fluctuations.
Analyzing the technical data, the stocks recent price movement indicates a positive trend, with the last price at 12.60 SEK, above both its 20-day Simple Moving Average (SMA20) of 11.66 SEK and its 50-day Simple Moving Average (SMA50) of 10.84 SEK. The stock is also above its 200-day Simple Moving Average (SMA200) of 9.01 SEK, suggesting a long-term uptrend. The Average True Range (ATR) is 0.39, equivalent to 3.11%, indicating moderate volatility. The stock has reached a 52-week high of 12.75 SEK and a low of 7.59 SEK, showing significant price appreciation over the past year.
From a fundamental perspective, Acrinova AB has a market capitalization of 878.86M SEK, with a Price-to-Earnings (P/E) ratio of 15.24, indicating that the stock might be reasonably valued compared to its earnings. The Return on Equity (RoE) stands at 5.94%, suggesting that the company is generating a decent return for its shareholders, although there is room for improvement. The absence of a forward P/E ratio makes it challenging to assess future earnings expectations.
Forecasting the stocks future performance based on the available technical and fundamental data, we can anticipate continued growth due to the companys diversified property portfolio and the overall positive trend in the stocks price. The uptrend indicated by the stock being above its SMAs, coupled with a reasonable P/E ratio and a decent RoE, supports a cautiously optimistic outlook. However, the moderate volatility, as indicated by the ATR, suggests that investors should be prepared for potential fluctuations. As such, a potential forecast could see the stock testing its 52-week high in the near term, potentially breaking through to new highs if the companys fundamentals continue to improve and the real estate market in Sweden remains favorable.
Additional Sources for ACRI-B Stock
ACRI-B Stock Overview
Market Cap in USD | 93m |
Sector | Real Estate |
Industry | Real Estate - Diversified |
GiC Sub-Industry | Real Estate Operating Companies |
IPO / Inception |
ACRI-B Stock Ratings
Growth Rating | 17.4 |
Fundamental | 31.0 |
Dividend Rating | 61.3 |
Rel. Strength | 43.4 |
Analysts | - |
Fair Price Momentum | 14.91 SEK |
Fair Price DCF | 13.12 SEK |
ACRI-B Dividends
Dividend Yield 12m | 11.81% |
Yield on Cost 5y | 13.53% |
Annual Growth 5y | -6.29% |
Payout Consistency | 84.5% |
Payout Ratio | 1.5% |
ACRI-B Growth Ratios
Growth Correlation 3m | 96.3% |
Growth Correlation 12m | 55.9% |
Growth Correlation 5y | -20.6% |
CAGR 5y | 7.82% |
CAGR/Max DD 5y | 0.15 |
Sharpe Ratio 12m | -0.12 |
Alpha | 60.49 |
Beta | -0.448 |
Volatility | 44.34% |
Current Volume | 6.4k |
Average Volume 20d | 10.2k |
As of June 27, 2025, the stock is trading at SEK 12.75 with a total of 6,415 shares traded.
Over the past week, the price has changed by -0.78%, over one month by +12.86%, over three months by +51.81% and over the past year by +60.86%.
Neither. Based on ValueRay´s Fundamental Analyses, Acrinova Series is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.98 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACRI-B is around 14.91 SEK . This means that ACRI-B is currently undervalued and has a potential upside of +16.94% (Margin of Safety).
Acrinova Series has no consensus analysts rating.
According to our own proprietary Forecast Model, ACRI-B Acrinova Series will be worth about 16.1 in June 2026. The stock is currently trading at 12.75. This means that the stock has a potential upside of +26.27%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 16.1 | 26.3% |